CIK 0001281895 · Non-accelerated filer<br>Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $405,500
- in 5 filings
Net −$405,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-21 | Militello John See Remarks | Sale | −2,737 | $10.58 | $29K | 65,757 |
| 2025-02-21 | Shah Gaurav CEO | Sale | −16,303 | $10.58 | $172K | 772,680 |
| 2025-02-11 | Wilson Martin General Counsel | Grant or award | +90,358 | 153,918 | ||
| 2025-02-11 | Wilson Martin General Counsel | Grant or award · Stock Option (Right to Buy) | +134,642 | 134,642 | ||
| 2025-02-11 | Shah Gaurav CEO | Grant or award | +81,655 | 788,983 | ||
| 2025-02-11 | Shah Gaurav CEO | Grant or award · Stock Option (Right to Buy) | +243,345 | 243,345 | ||
| 2025-02-11 | Schwartz Jonathan David See Remarks | Grant or award | +80,318 | 252,731 | ||
| 2025-02-11 | Schwartz Jonathan David See Remarks | Grant or award · Stock Option (Right to Buy) | +119,682 | 119,682 | ||
| 2025-02-11 | Patel Kinnari See Remarks | Grant or award | +57,786 | 450,181 | ||
| 2025-02-11 | Patel Kinnari See Remarks | Grant or award · Stock Option (Right to Buy) | +172,214 | 172,214 | ||
| 2025-02-11 | Ondrey Aaron Chief Financial Officer | Grant or award | +90,358 | 137,139 | ||
| 2025-02-11 | Ondrey Aaron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +134,642 | 134,642 | ||
| 2025-02-11 | Militello John See Remarks | Grant or award | +20,080 | 68,494 | ||
| 2025-02-11 | Militello John See Remarks | Grant or award · Stock Option (Right to Buy) | +29,920 | 29,920 | ||
| 2025-02-03 | Pratumsuwan Piratip Director | Grant or award · Stock Option (Right to Buy) | +51,181 | 51,181 | ||
| 2025-02-03 | Pratumsuwan Piratip Director | Grant or award · Stock Option (Right to Buy) | +22,443 | 22,443 | ||
| 2025-01-23 | Militello John See Remarks | Sale | −896 | $10.38 | $9K | 48,414 |
| 2024-12-12 | RTW INVESTMENTS, LP Director | Grant or award · Pre-funded Warrant (right to buy) | +400,000 | $12.49 | $5.0M | 3,526,955 |
| 2024-11-21 | Schwartz Jonathan David See Remarks | Sale | −3,097 | $13.05 | $40K | 163,852 |
| 2024-11-21 | Militello John See Remarks | Sale | −1,224 | $13.05 | $16K | 49,310 |
Page 8 of 9 · 164 trades